Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth

Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growthCombination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth, Published online: 29 March 2019; doi:10.1038/s41434-019-0071-xCombination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth

Source: Gene Therapy - March 28, 2019 Category: Genetics & Stem Cells Authors: Rodrigo Esaki Tamura Marlous G. Lana Eugenia Costanzi-Strauss Bryan E. Strauss Source Type: research